Exhibit
23.2
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We
consent to the incorporation by reference in this Registration Statement of Nile
Therapeutics, Inc. on Form S-3 of our report dated March 10, 2009, on the
financial statements of Nile Therapeutics, Inc. as of December 31, 2008 and
for the year then ended (which report expresses an unqualified opinion and
includes and explanatory paragraph relating to Nile Therapeutics, Inc.’s ability
to continue as a going concern) appearing in the 2009 Form 10-K of Nile
Therapeutics, Inc. and to the reference to us under the heading “Experts” in the
prospectus
|
/s/
Hays & Company LLP
|
|
|
|
|
|
New
York, New York
|
|
|
March
2, 2010
|
|